188 related articles for article (PubMed ID: 38356711)
1. Aspartate β-hydroxylase Regulates Expression of
Kanwal M; Smahelova J; Ciharova B; Johari SD; Nunvar J; Olsen M; Smahel M
J Cancer; 2024; 15(5):1138-1152. PubMed ID: 38356711
[No Abstract] [Full Text] [Related]
2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous Response of Tumor Cell Lines to Inhibition of Aspartate β-hydroxylase.
Kanwal M; Polakova I; Olsen M; Kasi MK; Tachezy R; Smahel M
J Cancer; 2024; 15(11):3466-3480. PubMed ID: 38817852
[No Abstract] [Full Text] [Related]
4. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis
Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J
Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101
[TBL] [Abstract][Full Text] [Related]
5. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
[TBL] [Abstract][Full Text] [Related]
6. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
[TBL] [Abstract][Full Text] [Related]
7. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
[TBL] [Abstract][Full Text] [Related]
8. Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome.
Luo L; McGarvey P; Madhavan S; Kumar R; Gusev Y; Upadhyay G
Oncotarget; 2016 Mar; 7(10):11165-93. PubMed ID: 26862846
[TBL] [Abstract][Full Text] [Related]
9. Aspartate β-hydroxylase as a target for cancer therapy.
Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
[TBL] [Abstract][Full Text] [Related]
10. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer.
Benelli R; Costa D; Mastracci L; Grillo F; Olsen MJ; Barboro P; Poggi A; Ferrari N
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295249
[TBL] [Abstract][Full Text] [Related]
11. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
[TBL] [Abstract][Full Text] [Related]
12. miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer.
Chen X; Jin P; Tang H; Zhang L
Int J Clin Exp Pathol; 2019; 12(9):3384-3389. PubMed ID: 31934181
[TBL] [Abstract][Full Text] [Related]
13. Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors.
Brewitz L; Tumber A; Pfeffer I; McDonough MA; Schofield CJ
Sci Rep; 2020 May; 10(1):8650. PubMed ID: 32457455
[TBL] [Abstract][Full Text] [Related]
14. Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.
Sturla LM; Tong M; Hebda N; Gao J; Thomas JM; Olsen M; de la Monte SM
Heliyon; 2016 Dec; 2(12):e00203. PubMed ID: 27981247
[TBL] [Abstract][Full Text] [Related]
15. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Liu D; Bai X; Sun B; Hung MC; Liu L; Wands JR; Dong X
Am J Cancer Res; 2021; 11(6):2537-2567. PubMed ID: 34249415
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
[TBL] [Abstract][Full Text] [Related]
17. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of circ-ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR-599/AR/SOCS2-AS1 signaling pathway.
Qu Y; Qi L; Hao L; Zhu J
Oncol Lett; 2021 May; 21(5):388. PubMed ID: 33777211
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
Zhang Y; Gao Y; Li Y; Zhang X; Xie H
Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
[TBL] [Abstract][Full Text] [Related]
20. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.
Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR
Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
